NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
The American Diabetes Association’s 2023 Standards of Care reflect changes in technology, improved medications, and a deeper understanding of the social factors that contribute to disease and diabetes control
The American Diabetes Association (ADA) publishes annually-updated Standards of Care in Diabetes – comprehensive, evidence-based guidelines for the prevention, diagnosis, and treatment of diabetes.
Based on the latest scientific research and clinical trials, the 2023 Standards of Care include new and updated practice guidelines to care for people with diabetes and pre-diabetes, including for the diagnosis and treatment of youths and adults with type 1, type 2, or gestational diabetes; strategies for the prevention or delay of type 2 diabetes and associated comorbidities; and therapeutic approaches that can reduce complications, mitigate cardiovascular and renal risk, and improve health outcomes.
“The field of diabetes is changing fast. ADA’s Standards of Care strives to provide up-to-date guidance using the best available evidence rigorously and comprehensively,” said Dr Nuha El Sayed, the ADA’s Professional Practice Committee Chair.
This year, the ADA Standards in Care included almost 100 new or revised recommendations affecting all types of diabetes. New guidelines include updates to recommendations around obesity, hypertension, heart failure medication, social determinants of health, and lipid management.
“This year’s annual report provides necessary guidance that considers the role health inequities play in the development of diabetes, particularly for vulnerable communities and communities of colour disproportionately impacted by the disease. This guidance will ensure healthcare teams, clinicians, and researchers treat the whole person,” said Chuck Henderson, Chief Executive Officer for the ADA.
Throughout the 2023 guidance and within the treatment algorithms, weight loss is now given equal importance to glycaemic control, cardiovascular disease, heart failure, and renal disease. Encouragement to lose weight should underpin type 2 diabetes care the guidance says:
Notable updates to the Standards of Care in Diabetes 2023 include:
Other noteworthy changes to the 2023 Standards of Care include:
The ADA 2023 Standards of Care can be accessed here: https://diabetesjournals.org/care/issue/46/Supplement_1
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
An exploration of whether different joints have different treatment outcomes was the subject of a large...
Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR...
ADVERTISEMENT
Three model 3 hospital sites have been chosen to implement a series of reforms recommended by...
Weekly face-to-face sessions are only one aspect of a GP’s duties. The most frequent and annoying...
'Virtual wards’ are set to be operationalised at University Hospital Limerick and St Vincent’s UniversityHospital in...
As older doctors retire, a new generation has arrived with different professional and personal priorities. Around...
ADVERTISEMENT
ADVERTISEMENT
Leave a Reply
You must be logged in to post a comment.